Brexafemme Approved For Recurrent Yeast Infections
The Food and Drug Administration (FDA) has approved Brexafemme for a second indication for reduction in incidence of recurrent vulvovaginal…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.